Cognivue Inc. in Victor recently appointed Reina Benabou as senior vice president and chief medical officer, and Whitney Parachek as VP of sales.
The growth in the Cognivue leadership team better positions the company, owned by Tom Golisano, as its expands awareness of its computerized cognitive test.
“Making a difference in the lives of patients has always been one of our goals at Cognivue,” said Tom O’Neill, president and CEO. “Now that Dr. Benabou and Ms. Parachek are on board, we have the resources to help more people than ever before. The successes they’ve generated throughout their careers speaks volumes about their characters and capabilities. To have them as a part of the Cognivue team will have a tremendous impact on the company, physicians and patients alike.”
Benabou is a global clinical developer and medical affairs pharmaceutical executive. She started her pharmaceutical career at Schering Plough in 2003, and held executive positions at Pfizer, Novartis and AstraZeneca. Throughout her career, she received awards for her patient-focused philosophy, cross-functional collaboration, high business impact and exemplary leadership.
Benabou has a Doctor of Medicine degree from Sao Paulo. She received neurology training and research fellowships from McGill University in Canada, and earned a doctorate in neurological sciences from the University of Montreal.
Parachek has more than 20 years of experience leading and developing high-performance teams in the health care and device sector. She previously worked as VP of sales for the Gynecologic Surgical Division of Hologic, where she was responsible for leading more than 250 employees to double-digit growth in a $400 million business.
She earned a Bachelor of Science in kinesiology from the College of Charleston in South Carolina.
These leadership appointments were announced with the launch of the Cognivue Advanced. This risk assessment tool helps doctors objectively, quantitatively and reliably diagnose changes in a person’s thinking, reasoning or memory, and prescribe proper treatment and management options. Cognitive impairment is associated with Alzheimer’s, multiple sclerosis, migraines, sleep disorders, and other illnesses and health problems.